scispace - formally typeset
D

Donald A. Goldmann

Researcher at Boston Children's Hospital

Publications -  353
Citations -  29552

Donald A. Goldmann is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Health care & Intensive care. The author has an hindex of 94, co-authored 345 publications receiving 28089 citations. Previous affiliations of Donald A. Goldmann include Boston University & United States Public Health Service.

Papers
More filters
Journal ArticleDOI

Score for neonatal acute physiology : a physiologic severity index for neonatal intensive care

TL;DR: The Score for Neonatal Acute Physiology (SNAP) was developed and validated prospectively on 1643 admissions (114 deaths) in three NICUs and showed little correlation with birth weight and was highly predictive of neonatal mortality even within narrow birth weight strata.
Journal ArticleDOI

Prioritizing strategies for preventing medication errors and adverse drug events in pediatric inpatients.

TL;DR: Of the assessed interventions, computerized physician order entry with clinical decision support systems; ward-based clinical pharmacists; and improved communication among physicians, nurses, and pharmacists had the greatest potential to reduce medication errors in pediatric inpatients.
Journal ArticleDOI

Coagulase-Negative Staphylococci: Role as Pathogens

TL;DR: Coagulase-negative staphylococci are by far the most common cause of bacteremia related to indwelling devices and their important role as pathogens and their increasing incidence have been recognized and studied in recent years.
Journal Article

Guideline for prevention of nosocomial pneumonia.

TL;DR: In this guideline, no distinction is made between pneumonia and other lower respiratory tract infections, such as purulent bronchitis or lung abscess, and isolation techniques used to prevent transmission of microorganisms involved in pneumonia are mentioned only briefly.
Journal ArticleDOI

Broadly Protective Vaccine for Staphylococcus aureus Based on an in Vivo-Expressed Antigen

TL;DR: PNSG is a candidate for use in a vaccine to protect against S. aureus infection and protected mice against kidney infections and death from strains that produced little PNSG in vitro.